What it is
A compounded peptide protocol in injectable format, prepared per order and shipped as a complete monthly cycle.
Shop / Treatments
Peptides for recovery and lean mass
Strength treatments
Peptide protocols aimed at recovery, lean muscle support and training capacity, compounded to order and shipped straight to you.
- Faster post-training recovery
- Lean mass and performance support
Your options
Explore strength treatments
Compare formulations and review each treatment’s science, safety information and available options.
Loading treatments…
Understanding the approach
About strength
Peptides are short chains of amino acids — the same building blocks your body already uses to signal repair and growth. Targeted peptide protocols are designed to support the recovery side of training: the hours between workouts where progress actually happens.
Our strength line is built for people who train consistently and want their recovery to keep up. Formulations are compounded to order at 503A pharmacies and arrive as a complete monthly cycle with a straightforward protocol card.
No guesswork, no juggling five different supplements — just one protocol, one schedule, and everything you need in the box.
What it is
How it works
Who it's for
The evidence
Science & research
Research describes the studied ingredient, population and delivery method—not a guarantee of results from this compounded formulation. Evidence may be preliminary or based on laboratory, animal or precursor studies. Your clinician determines whether treatment is appropriate. Compounded medications are not FDA-approved.
The TRAVERSE trial (NEJM, 2023) found testosterone therapy did not increase major cardiovascular events in men with low testosterone and elevated heart risk.
Subcutaneous testosterone delivery has been shown to achieve stable, normal-range levels in clinical studies.
The TRAVERSE trial (NEJM, 2023) found testosterone therapy did not increase major cardiovascular events in men with low testosterone and elevated heart risk.
The Testosterone Trials (NEJM, 2016) showed improvements in sexual function, mood and walking distance in older men with low testosterone.
Phase 3 studies (Kim et al., BJU International 2016) showed enclomiphene raised testosterone into the normal range while maintaining sperm counts, unlike topical testosterone.
Anastrozole is FDA-approved for breast cancer; small studies in men (e.g., Leder et al., J Clin Endocrinol Metab 2004) show it lowers estradiol and raises testosterone.
Hsieh et al. (Journal of Urology, 2013) found low-dose HCG with testosterone preserved semen parameters in men on therapy.
Growth hormone is released by the pituitary gland in pulses, the largest of which happens during deep sleep. Sermorelin binds to the same receptor as the body's own GHRH and prompts the pituitary to release growth hormone in that same pulsed pattern.
Because the pituitary stays in control, the body's normal feedback loop remains intact. When growth hormone and IGF-1 rise, the pituitary slows its own release, which is one reason sermorelin is studied as a more physiologic approach than injecting growth hormone directly.
The tablet is a needle-free option, compounded in 2 mg and 5 mg strengths so your provider can set the dose to your goals. It is taken daily at bedtime.
Clinical studies (Walker, Clinical Interventions in Aging 2006) showed sermorelin increases growth hormone and IGF-1 in older adults while preserving natural feedback controls.
Personalized care
From selection to ongoing support
Common questions
Strength FAQs
Explore other treatment goals
Your next step